FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia

In 2016, the American Academy of Neurology (AAN) published practice guidelines for botulinum toxin (BoNT) in the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. This article, focusing on dystonia, provides context for these guidelines through literature review. Studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Spiegel, Lauren L., Ostrem, Jill L., Bledsoe, Ian O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290737/
https://www.ncbi.nlm.nih.gov/pubmed/32429600
http://dx.doi.org/10.3390/toxins12050332

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290737/
https://www.ncbi.nlm.nih.gov/pubmed/32429600
http://dx.doi.org/10.3390/toxins12050332

Ejemplares similares